These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 22806406)

  • 21. Following the concentration of polymeric nanoparticles during nebulization.
    Beck-Broichsitter M; Knuedeler MC; Schmehl T; Seeger W
    Pharm Res; 2013 Jan; 30(1):16-24. PubMed ID: 22806406
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of lyoprotectants for the stabilization of biodegradable nanoparticles on the performance of air-jet, ultrasonic, and vibrating-mesh nebulizers.
    Beck-Broichsitter M; Kleimann P; Schmehl T; Betz T; Bakowsky U; Kissel T; Seeger W
    Eur J Pharm Biopharm; 2012 Oct; 82(2):272-80. PubMed ID: 22820646
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Boosting the aerodynamic properties of vibrating-mesh nebulized polymeric nanosuspensions.
    Beck-Broichsitter M; Knuedeler MC; Oesterheld N; Seeger W; Schmehl T
    Int J Pharm; 2014 Jan; 459(1-2):23-9. PubMed ID: 24286921
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Systematic aging of degradable nanosuspension ameliorates vibrating-mesh nebulizer performance.
    Dalla-Bona AC; Schmehl T; Gessler T; Seeger W; Beck-Broichsitter M
    Drug Dev Ind Pharm; 2015; 41(10):1704-9. PubMed ID: 25519975
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nebulization of biodegradable nanoparticles: impact of nebulizer technology and nanoparticle characteristics on aerosol features.
    Dailey LA; Schmehl T; Gessler T; Wittmar M; Grimminger F; Seeger W; Kissel T
    J Control Release; 2003 Jan; 86(1):131-44. PubMed ID: 12490379
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Controlled pulmonary drug and gene delivery using polymeric nano-carriers.
    Beck-Broichsitter M; Merkel OM; Kissel T
    J Control Release; 2012 Jul; 161(2):214-24. PubMed ID: 22192571
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of novel spray-dried polymeric particles for controlled pulmonary drug delivery.
    Beck-Broichsitter M; Schweiger C; Schmehl T; Gessler T; Seeger W; Kissel T
    J Control Release; 2012 Mar; 158(2):329-35. PubMed ID: 22063006
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nebulization performance of biodegradable sildenafil-loaded nanoparticles using the Aeroneb Pro: formulation aspects and nanoparticle stability to nebulization.
    Beck-Broichsitter M; Kleimann P; Gessler T; Seeger W; Kissel T; Schmehl T
    Int J Pharm; 2012 Jan; 422(1-2):398-408. PubMed ID: 22001839
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The potential for inhaled treprostinil in the treatment of pulmonary arterial hypertension.
    Gessler T; Seeger W; Schmehl T
    Ther Adv Respir Dis; 2011 Jun; 5(3):195-206. PubMed ID: 21300738
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of particle size on regional lung deposition--what evidence is there?
    Carvalho TC; Peters JI; Williams RO
    Int J Pharm; 2011 Mar; 406(1-2):1-10. PubMed ID: 21232585
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Surfactant-free redispersible nanoparticles in fast-dissolving composite microcarriers for dry-powder inhalation.
    Lebhardt T; Roesler S; Uusitalo HP; Kissel T
    Eur J Pharm Biopharm; 2011 May; 78(1):90-6. PubMed ID: 21145394
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aerosol drug delivery: developments in device design and clinical use.
    Dolovich MB; Dhand R
    Lancet; 2011 Mar; 377(9770):1032-45. PubMed ID: 21036392
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel 'nano in nano' composites for sustained drug delivery: biodegradable nanoparticles encapsulated into nanofiber non-wovens.
    Beck-Broichsitter M; Thieme M; Nguyen J; Schmehl T; Gessler T; Seeger W; Agarwal S; Greiner A; Kissel T
    Macromol Biosci; 2010 Dec; 10(12):1527-35. PubMed ID: 20824691
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pulmonary gene silencing in transgenic EGFP mice using aerosolised chitosan/siRNA nanoparticles.
    Nielsen EJ; Nielsen JM; Becker D; Karlas A; Prakash H; Glud SZ; Merrison J; Besenbacher F; Meyer TF; Kjems J; Howard KA
    Pharm Res; 2010 Dec; 27(12):2520-7. PubMed ID: 20824309
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preparation of nanoparticles by solvent displacement for drug delivery: a shift in the "ouzo region" upon drug loading.
    Beck-Broichsitter M; Rytting E; Lebhardt T; Wang X; Kissel T
    Eur J Pharm Sci; 2010 Oct; 41(2):244-53. PubMed ID: 20600881
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Update on macrophage clearance of inhaled micro- and nanoparticles.
    Geiser M
    J Aerosol Med Pulm Drug Deliv; 2010 Aug; 23(4):207-17. PubMed ID: 20109124
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pulmonary targeting with biodegradable salbutamol-loaded nanoparticles.
    Beck-Broichsitter M; Gauss J; Gessler T; Seeger W; Kissel T; Schmehl T
    J Aerosol Med Pulm Drug Deliv; 2010 Feb; 23(1):47-57. PubMed ID: 19778266
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro and in vivo performance of biocompatible negatively-charged salbutamol-loaded nanoparticles.
    Rytting E; Bur M; Cartier R; Bouyssou T; Wang X; Krüger M; Lehr CM; Kissel T
    J Control Release; 2010 Jan; 141(1):101-7. PubMed ID: 19720096
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lipid nanocapsules: ready-to-use nanovectors for the aerosol delivery of paclitaxel.
    Hureaux J; Lagarce F; Gagnadoux F; Vecellio L; Clavreul A; Roger E; Kempf M; Racineux JL; Diot P; Benoit JP; Urban T
    Eur J Pharm Biopharm; 2009 Oct; 73(2):239-46. PubMed ID: 19560538
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.